Peripheral Blood Stem Cell Transplant

PROCEDURE9 trials

Conditions

Acute LeukemiaAcute Lymphocytic LeukemiaAcute Myeloblastic LeukemiaAcute Myelogenous LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute LeukemiaBurkitt LymphomaCMML

Phase 1

Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen

CompletedNCT00556452

University of Michigan Rogel Cancer CenterHodgkin Lymphoma, Leukemia, Multiple Myeloma +2

Start: 2007-10-31End: 2012-09-30Updated: 2017-12-05

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

CompletedNCT01203722

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsHematologic Malignancies

Start: 2010-09-01End: 2024-05-28Updated: 2026-02-19

Phase 2

Therapy for Children With Advanced Stage High Risk Neuroblastoma

CompletedNCT00186849

St. Jude Children's Research HospitalNeuroblastoma

Start: 1997-10-31End: 2001-04-30Updated: 2009-05-20

Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases

CompletedNCT01336712

Northside Hospital, Inc.Acute Leukemia, Chronic Leukemia, Hodgkin's Disease +2

Start: 2011-04-30End: 2015-07-31Updated: 2016-01-14

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

CompletedNCT01457885

University of Michigan Rogel Cancer CenterAcute Myeloblastic Leukemia

Start: 2011-11-30End: 2016-06-14Updated: 2017-06-02

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

CompletedNCT02581007

Northside Hospital, Inc.Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia +7

Start: 2015-10-26End: 2020-12-28Updated: 2023-04-27

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

CompletedNCT03961919

Ciceri FabioAcute Myeloid Leukemia, Myelodysplastic Syndromes, Transplant-Related Hematologic Malignancy

Start: 2009-02-10End: 2021-12-31Updated: 2023-11-18

Allo HSCT Using RIC and PTCy for Hematological Diseases

RecruitingNCT05805605

Masonic Cancer Center, University of MinnesotaAcute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia +15

Start: 2023-05-01End: 2028-10-22Target: 56Updated: 2025-07-01

Unknown Phase

Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors

TerminatedNCT00966498

Emory UniversityHigh Risk Solid Tumors, Recurrent Solid Tumors

Start: 2003-05-31End: 2011-07-31Updated: 2013-12-11

Related Papers

Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide

Transplantation and Cellular Therapy2021-08-2016 citations

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Blood Advances2017-01-0698 citations

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

2011-08-1244 citations